These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23074697)

  • 1. Omeprazole-induced blood dyscrasia in a clozapine-treated patient.
    Philipps RJ; Lee Demler T; Lee C
    Innov Clin Neurosci; 2012 Sep; 9(9):14-7. PubMed ID: 23074697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.
    Gouraud A; Vochelle V; Descotes J; Vial T
    Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Mechanisms of Hematological Adverse Drug Reactions in Patients Receiving Clozapine in Combination With Proton Pump Inhibitors.
    Wiciński M; Węclewicz MM; Miętkiewicz M; Malinowski B; Grześk E; Klonowska J
    J Psychiatr Pract; 2017 Mar; 23(2):114-120. PubMed ID: 28291036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).
    Balda MV; Garay OU; Papale RM; Bignone I; Bologna VG; Brandolini A; Prokopez CR; Balasini JI; Baldessarini RJ; Daray FM
    Int Clin Psychopharmacol; 2015 Mar; 30(2):109-14. PubMed ID: 25486383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
    Herceg M; Muzinić L; Jukić V
    Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA; Kerwin RW
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of the proton-pump inhibitors.
    Reilly JP
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections associated with clozapine: a pharmacovigilance study using VigiBase
    Chrétien B; Brazo P; Da Silva A; Sassier M; Dolladille C; Lelong-Boulouard V; Alexandre J; Fedrizzi S
    Front Pharmacol; 2023; 14():1260915. PubMed ID: 37849735
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Sudden Very Late Onset of Severe Clozapine-induced Agranulocytosis Following an Influenza Vaccine.
    Jean S; Romain L; Florvil S; Heyliger FG; Mandal A
    Cureus; 2019 May; 11(5):e4682. PubMed ID: 31328073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agranulocytosis induced by proton pump inhibitors.
    Dury S; Nardi J; Gozalo C; Lebargy F; Deslee G
    J Clin Gastroenterol; 2012; 46(10):859. PubMed ID: 22240865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine Rechallenge After Neutropenia or Leucopenia.
    Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
    J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of proton pump inhibitors--an overview.
    Arnold R
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():65-70. PubMed ID: 8180297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential effect of polypharmacy on the hematologic profiles of clozapine patients.
    Shuman MD; Trigoboff E; Demler TL; Opler LA
    J Psychiatr Pract; 2014 Jan; 20(1):50-8. PubMed ID: 24419309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.